J&J, Legend's Carvykti delivers encouraging early growth ahead of key myeloma readout

J&J, Legend's Carvykti delivers encouraging early growth ahead of key myeloma readout

[ad_1]

In hot pursuit of Bristol Myers Squibb and 2seventy bio’s first-to-market Abecma, Johnson & Johnson and Legend Biotech’s CAR-T therapy Caryvkti has shown an encouraging sign of growth. | In hot pursuit of Bristol Myers Squibb and 2seventy bio’s first-to-market Abecma, Johnson & Johnson and Legend Biotech’s CAR-T therapy Caryvkti has shown an encouraging sign of growth.

[ad_2]

Source link

admin

Leave a Reply

Your email address will not be published. Required fields are marked *